Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Market Cap	39.75M 46.13M 37.64M 34.11M 64M 4.41B 64.32M 447M 172M 2.24B 173M 169M 7.09B	P/E 2026 *	-7.69x	P/E 2027 *	57.7x
Enterprise Value	50.9M 59.07M 48.19M 43.68M 81.95M 5.64B 82.37M 572M 220M 2.87B 222M 217M 9.07B	EV / Sales 2026 *	9.98x	EV / Sales 2027 *	3.32x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

09-09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
04-28	Amoéba secures emergency authorization for downy mildew treatment in France
04-13	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI
03-26	Amoéba Raises EUR7 Million via Private Placement	MT

09-10	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL
09-09	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL
09-08	Amoéba : Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	AT
07-23	Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides	AT
07-01	Amoéba has received marketing authorization in France for its biofungicide AXPERA	GL

09-10	Syngenta en Amoéba hebben een exclusieve distributieovereenkomst in Europa gesloten om graanproducenten een innoverend biofungicide te bieden
09-10	Syngenta e Amoéba hanno concluso un accordo di distribuzione esclusiva in Europa per proporre ai produttori di cereali un'innovazione biofungicida
09-10	Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
09-10	Syngenta y Amoéba han suscrito un acuerdo de distribución exclusiva en Europa para ofrecer una innovación biofungicida a los productores cerealistas
09-10	Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	13/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	31/08/2018
Jean-Baptiste Eberst LAW	General Counsel	-	30/06/2015

Amoéba Share Price Euronext Paris

Stocks

Agricultural Chemicals

Valuation : Amoéba

Latest news : Amoéba

Press Releases : Amoéba

News in other languages : Amoéba

Managers and Directors : Amoéba

Pesticide

Financials

Company Profile

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	31/05/2014
Benoît Villers CHM	Chairman	70	13/12/2023
Jean-luc Souche BRD	Director/Board Member	70	24/05/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	-.--%	-11.21%	-	-	46.13M
JIANGSU YANGNONG CHEMICAL CO., LTD.	-4.64%	-2.56%	-27.62%	-17.37%	3.26B
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	+3.91%	+13.34%	+12.22%	+19.87%	2.51B
ADAMA LTD.	-3.03%	+1.94%	-16.62%	-29.03%	1.93B
LIER CHEMICAL CO.,LTD.	+1.20%	+1.95%	+22.77%	+14.43%	1.81B
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	-3.63%	-4.90%	-17.48%	+47.23%	1.49B
CAC NANTONG CHEMICAL CO., LTD.	-2.13%	-5.19%	-28.99%	-	1.48B
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	-2.62%	+0.09%	-10.84%	-46.90%	1.46B
NANTONG JIANGSHAN AGROCHEMICAL & CHEMICALS CO.,LTD.	-4.09%	+0.16%	-28.66%	-11.77%	1.2B
LIMIN GROUP CO.,LTD.	-5.49%	-4.70%	-18.19%	+84.45%	1.13B
Average	-2.05%	-0.23%	-12.60%	+7.61%	1.81B
Weighted average by Cap.	-1.99%	+0.52%	-11.68%	+3.11%

	2026 *	2027 *
Net sales	5.1M 5.92M 4.83M 4.38M 8.21M 565M 8.25M 57.35M 22.06M 288M 22.23M 21.74M 909M	15.55M 18.05M 14.72M 13.35M 25.04M 1.72B 25.16M 175M 67.25M 877M 67.78M 66.29M 2.77B
Net income	-5.2M -6.04M -4.92M -4.46M -8.37M -577M -8.41M -58.48M -22.49M -293M -22.67M -22.17M -927M	550K 638K 521K 472K 886K 60.98M 890K 6.19M 2.38M 31.03M 2.4M 2.34M 98.04M
Net Debt	11.15M 12.94M 10.56M 9.57M 17.95M 1.24B 18.04M 125M 48.22M 629M 48.6M 47.54M 1.99B	11.85M 13.75M 11.22M 10.17M 19.08M 1.31B 19.18M 133M 51.25M 668M 51.65M 50.52M 2.11B